neoplasias
DESCRIPTION
NEOPLASIAS. Luis Fernando Jaramillo G. www.robbinspathology.com. www.robbinspathology.com. Epidemiología:. TUMORES MALIGNOS EN HOMBRES (H.U.S.I) ORGANO No. % EDAD MEDIA Próstata 290 17,8 69,8 - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/1.jpg)
NEOPLASIAS.
Luis Fernando Jaramillo G.
![Page 2: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/2.jpg)
www.robbinspathology.com
![Page 3: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/3.jpg)
www.robbinspathology.com
![Page 4: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/4.jpg)
Epidemiología:
TUMORES MALIGNOS EN HOMBRES (H.U.S.I)
ORGANO No. % EDAD MEDIA
Próstata 290 17,8 69,8
Estómago 216 13,2 58,8
Vejiga 101 6,2 67,0
Colon 80 4,9 61,1
Recto 69 4,2 60,0
Ref: Carrera J, Jaramillo LF : Prevalencia de lesiones tumorales
malignas en el HUSI, Universitas Médica Vol 41 No.2, 2000
![Page 5: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/5.jpg)
Epidemiología:
TUMORES MALIGNOS EN MUJERES (H.U.S.I)
ORGANO No. % EDAD MEDIA
Cérvix 295 17,5 46,9
Mama 213 11,3 51,6
Estómago 115 6,1 58,8
Colon 93 4,9 61,1
Endometrio 80 4,2 58,8
Ref: Carrera J, Jaramillo LF : Prevalencia de lesiones tumorales
malignas en el HUSI, Universitas Médica Vol 41 No.2, 2000
![Page 6: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/6.jpg)
Epidemiología:
![Page 7: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/7.jpg)
![Page 8: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/8.jpg)
Aspectos clínicos:
Síntomas:
• Efectos locales • Efectos por las metástasis.• Síndromes paraneoplásicos.• Impacto emocional.• Impacto social.• Impacto familiar.
![Page 9: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/9.jpg)
Aspectos clínicos:
Signos y Síntomas:
• Fiebre.
• Anorexia y pérdida de peso.
• Dolor.
• Masa.
![Page 10: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/10.jpg)
![Page 11: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/11.jpg)
![Page 12: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/12.jpg)
![Page 13: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/13.jpg)
![Page 14: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/14.jpg)
![Page 15: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/15.jpg)
![Page 16: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/16.jpg)
Aspectos clínicos:
Síndromes paraneoplásicos: • Síndromes endocrinos.• Síndromes nerviosos y musculares.• Síndromes hematológicos.• Síndromes gastrointestinales.• Síndrome nefrótico.• Síndromes cutáneos.• Amiloidosis.
![Page 17: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/17.jpg)
![Page 18: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/18.jpg)
Paraneoplastic syndromes
Syndrome Mechanism Example
Cushing's Syndrome ACTH-like substance Lung (oat cell) carcinoma
Hypercalcemia Parathormone-like substance
Lung (squamous cell) carcinoma
Hyponatremia Inappropriate ADH secretion
Lung (oat cell) carcinoma
Polycythemia Erythropoietin-like substance
Renal cell carcinoma
Trousseau's Syndrome Hypercoagulable state Various carcinomas
Hypoglycemia Insulin-like substance Various carcinomas and sarcomas
Carcinoid Syndrome 5-hydroxy-indoleacetic acid (5-HIAA)
Metastatic malignant carcinoid tumors
![Page 19: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/19.jpg)
Aspectos clínicos:
Síndromes paraneoplásicos: • Síndromes neurológicos:
Médula Espinal:
- Neuropatía motora subaguda: asociación con linfomas.
- Esclerosis lateral amiotrófica: 10% con cáncer.
S.N.P.:
- Neuropatía periférica sensitivo-motora.
- Neuropatías autónomas y gastrointestinales.
![Page 20: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/20.jpg)
Aspectos clínicos:
Síndromes paraneoplásicos: • Síndromes hematológicos:
- Eritrocitosis: Carcinomas renales.
- Anemia: Carcinomas T.G.I., ginecológicos, etc.
- Trombosis venosa: CA renales, páncreas, pulmón, mama, ovario, etc.
- C.I.D.: leucemias.• Síndromes gastrointestinales:
- Malabsorción.
- Hipoalbuminemia.
![Page 21: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/21.jpg)
Aspectos clínicos:
Síndromes paraneoplásicos: • Síndrome nefrótico: - Nefrosis lipoidea. - Depósitos de complejos inmunes. - Complicación de amiloidosis o trombosis renal.• Síndromes cutáneos: - Acantosis nigricans: CA pulmón o T.G.I. - Dermatitis exfoliativa: linfomas.• Amiloidosis: - 15% asociados a cáncer (mieloma múltiple).
![Page 22: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/22.jpg)
Tratamiento:
• Cirugía.
• Radioterapia.
• Quimioterapia.
•Apoyo psicológico.•Apoyo familiar.•Soporte espiritual.
![Page 23: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/23.jpg)
![Page 24: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/24.jpg)
![Page 25: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/25.jpg)
![Page 26: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/26.jpg)
![Page 27: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/27.jpg)
![Page 28: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/28.jpg)
![Page 29: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/29.jpg)
PREVENCIÓN Y EDUCACIÓN
![Page 30: NEOPLASIAS](https://reader035.vdocument.in/reader035/viewer/2022062723/56813b55550346895da44550/html5/thumbnails/30.jpg)